Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03510988 · ClinicalTrials.gov registry record · NA
Dedicated Breast PET/MRI in Evaluation of Extent of Disease in Women With Newly Diagnosed Breast Cancer
A NA study, sponsored by Weill Medical College of Cornell University.
- Terminated
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT03510988 is a NA study that was terminated before completion, run by Weill Medical College of Cornell University. The registered enrollment target is 14 participants.
The verdict
NCT03510988, a NA study, was terminated before completion, sponsored by Weill Medical College of Cornell University.
- TERMINATED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
This is a single institution study enrolling women over age 25 with newly diagnosed breast cancer and for whom a breast MR has been ordered as standard of care. Subjects will undergo a hybrid dedicated Breast PET/MRI in lieu of a breast MRI alone, for evaluation of extent of disease prior to surgical and oncologic management. The study will investigate any incremental added benefit to breast MRI specificity by the addition of concurrent hybrid breast PET.
Interventions
- DIAGNOSTIC_TEST Hybrid breast FDG PET/MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2018-03-15 |
| Est. Completion | 2022-03-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03510988
The ClinicalTrials.gov registry entry for NCT03510988 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hybrid breast FDG PET/MRI is the first listed.
NCT03510988 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03510988 about?
NCT03510988 is a clinical study titled "Dedicated Breast PET/MRI in Evaluation of Extent of Disease in Women With Newly Diagnosed Breast Cancer". This is a single institution study enrolling women over age 25 with newly diagnosed breast cancer and for whom a breast MR has been ordered as standard of care. Subjects will undergo a hybrid dedicated Breast PET/MRI in lieu of a breast MRI alone, for evaluation of extent of disease prior to surgica...
What is the current status of trial NCT03510988?
This trial is currently terminated. It is a NA study. The enrollment target is 14 participants. The study started on 2018-03-15. Estimated completion is 2022-03-04.
What interventions are being tested in trial NCT03510988?
The interventions under investigation include: Hybrid breast FDG PET/MRI (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03510988?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.